Event Recap: Avoiding Common Traps in Commercial Launch
The commercial launch of a new drug is a make-or-break moment for a company. It represents the culmination of years…
Perspective
How Phase 3 Companies Can Better Navigate DSCSA Serialization Requirements
Ulpiano Flores, a business analyst with Converge Consulting, speaks about Phase 3 companies navigating DSCSA serialization requirements in an interview…